关注
PD Dr. Philipp Koehler
PD Dr. Philipp Koehler
University Hospital of Cologne
在 uk-koeln.de 的电子邮件经过验证
标题
引用次数
引用次数
年份
Remdesivir for the treatment of Covid-19
JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ...
New England Journal of Medicine 383 (19), 1813-1826, 2020
61592020
Remdesivir for the treatment of Covid-19—preliminary report
JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ...
New England Journal of Medicine 383 (19), 1813-1836, 2020
26672020
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
P Koehler, M Bassetti, A Chakrabarti, SCA Chen, AL Colombo, M Hoenigl, ...
The Lancet Infectious Diseases 21 (6), e149-e162, 2021
7752021
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
7522021
COVID‐19 associated pulmonary aspergillosis
P Koehler, OA Cornely, BW Böttiger, F Dusse, DA Eichenauer, F Fuchs, ...
Mycoses 63 (6), 528-534, 2020
6062020
COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
A Arastehfar, A Carvalho, FL van de Veerdonk, JD Jenks, P Koehler, ...
Journal of Fungi 6 (2), 91, 2020
4132020
Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19
JP Bernardes, N Mishra, F Tran, T Bahmer, L Best, JI Blase, D Bordoni, ...
Immunity 53 (6), 1296-1314. e9, 2020
3072020
Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19
P Bacher, E Rosati, D Esser, GR Martini, C Saggau, E Schiminsky, ...
Immunity 53 (6), 1258-1271. e5, 2020
2862020
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
FX Lescure, H Honda, RA Fowler, JS Lazar, G Shi, P Wung, N Patel, ...
The Lancet Respiratory Medicine 9 (5), 522-532, 2021
2682021
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
L Pagano, J Salmanton-García, F Marchesi, A Busca, P Corradini, ...
Journal of hematology & oncology 14 (1), 168, 2021
2652021
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the …
M Hoenigl, J Salmanton-García, TJ Walsh, M Nucci, CF Neoh, JD Jenks, ...
The Lancet Infectious Diseases 21 (8), e246-e257, 2021
2532021
Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis
P Koehler, M Stecher, OA Cornely, D Koehler, MJGT Vehreschild, ...
Clinical microbiology and infection 25 (10), 1200-1212, 2019
2312019
COVID-19–associated pulmonary aspergillosis, March–August 2020
J Salmanton-García, R Sprute, J Stemler, M Bartoletti, D Dupont, ...
Emerging infectious diseases 27 (4), 1077, 2021
2252021
Diagnosing COVID-19-associated pulmonary aspergillosis
PE Verweij, JP Gangneux, M Bassetti, RJM Brüggemann, OA Cornely, ...
The Lancet Microbe 1 (2), e53-e55, 2020
1942020
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of …
J Prattes, J Wauters, DR Giacobbe, J Salmanton-García, J Maertens, ...
Clinical Microbiology and Infection 28 (4), 580-587, 2022
1842022
COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry
MM Rüthrich, C Giessen-Jung, S Borgmann, AY Classen, S Dolff, ...
Annals of hematology 100, 383-393, 2021
1742021
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis
PE Verweij, RJM Brüggemann, E Azoulay, M Bassetti, S Blot, JB Buil, ...
Intensive care medicine 47 (8), 819-834, 2021
1352021
Long‐lived macrophage reprogramming drives spike protein‐mediated inflammasome activation in COVID‐19
SJ Theobald, A Simonis, T Georgomanolis, C Kreer, M Zehner, HS Eisfeld, ...
EMBO molecular medicine 13 (8), e14150, 2021
1202021
Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope®
D Seidel, A Meißner, M Lackner, E Piepenbrock, J Salmanton-García, ...
Critical reviews in microbiology 45 (1), 1-21, 2019
1202019
Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study
P Koehler, A Hamprecht, O Bader, I Bekeredjian-Ding, D Buchheidt, ...
International journal of antimicrobial agents 49 (2), 218-223, 2017
942017
系统目前无法执行此操作,请稍后再试。
文章 1–20